1. Home
  2. BNR vs CPZ Comparison

BNR vs CPZ Comparison

Compare BNR & CPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$16.20

Market Cap

252.7M

Sector

Health Care

ML Signal

HOLD

Logo Calamos Long/Short Equity & Dynamic Income Trust

CPZ

Calamos Long/Short Equity & Dynamic Income Trust

HOLD

Current Price

$13.64

Market Cap

269.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
CPZ
Founded
2014
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
252.7M
269.2M
IPO Year
2019
2017

Fundamental Metrics

Financial Performance
Metric
BNR
CPZ
Price
$16.20
$13.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
31.2K
89.7K
Earning Date
03-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$111.65
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.18
$13.13
52 Week High
$41.72
$16.82

Technical Indicators

Market Signals
Indicator
BNR
CPZ
Relative Strength Index (RSI) 35.63 36.41
Support Level $15.52 N/A
Resistance Level $23.42 $15.13
Average True Range (ATR) 1.39 0.28
MACD -0.01 -0.02
Stochastic Oscillator 11.27 40.16

Price Performance

Historical Comparison
BNR
CPZ

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About CPZ Calamos Long/Short Equity & Dynamic Income Trust

Calamos L/S Equity & Dynamic Inc Trust is a trust company that seeks to provide current income and risk-managed capital appreciation, with an investment objective to deliver total return through a combination of capital appreciation and current income. The Fund invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary, and others, and holds securities with a broad range of maturities, with the average term to maturity typically ranging from two to ten years. Managed assets represent the Fund's total assets, including any assets attributable to leverage that may be outstanding, minus total liabilities other than debt representing financial leverage.

Share on Social Networks: